Xiaolong Xu
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Molecular Biology top 10%
- Wnt/β-catenin signaling in development and cancer 5
- Bone Metabolism and Diseases 5
- RNA Research and Splicing 5
- Genomics, phytochemicals, and oxidative stress 4
- Genetics top 10%
- Mesenchymal stem cell research 5
- Pathology and Forensic Medicine top 10%
-
- Head and Neck Cancer Studies 5
-
- Cancer-related Molecular Pathways 4
- Co-authors
- Lei WeiYang GaoYihao TianJingwei ZhangLiu YangXiaoning YuanJiang PengZhuojing Luo
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaolong Xu
79 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 514
- Molecular Biology 1.1k
- Orthopedics and Sports Medicine 126
- Genetics 135
- Pathology and Forensic Medicine 209
Countries citing papers authored by Xiaolong Xu
This map shows the geographic impact of Xiaolong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Xu more than expected).
Fields of papers citing papers by Xiaolong Xu
This network shows the impact of papers produced by Xiaolong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Xu. The network helps show where Xiaolong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaolong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 12 | |
| 10 | CircRNA inhibits DNA damage repair by interacting with host genebreakdown → | 2020 | 280 |
| 11 | 2020 | 11 | |
| 12 | 2019 | 21 | |
| 13 | 2019 | 92 | |
| 14 | 2019 | 36 | |
| 15 | 2019 | 28 | |
| 16 | 2018 | 8 | |
| 17 | 2018 | 220 | |
| 18 | 2017 | 16 | |
| 19 | 2017 | 12 | |
| 20 | 2015 | 88 |
About Xiaolong Xu
Xiaolong Xu is a scholar working on Otorhinolaryngology, Cancer Research and Orthopedics and Sports Medicine, having authored 83 papers that have together received 1.9k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Bone Metabolism and Diseases (5 papers), MicroRNA in disease regulation (5 papers), Mesenchymal stem cell research (5 papers), RNA Research and Splicing (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (514 citations), Molecular Biology (1.1k citations) and Orthopedics and Sports Medicine (126 citations). Xiaolong Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lei Wei, Yang Gao, Yihao Tian, Jingwei Zhang, Liu Yang, Xiaoning Yuan, Jiang Peng, Zhuojing Luo, Weinan Yin and Chao Zheng. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.